The Executive Brain.
The name that took a beat too long. The paragraph you read twice. The edge that feels a half-step away. You noticed it before any metric did — and you are not imagining it.
Send My Free White PaperNormal Is Where We Start Looking
Among adults reporting subjective cognitive decline, only 45.4% ever discussed it with a clinician at all.
The silence is the norm, not the exception. Of those reporting functional difficulty, 73.3% said it interfered with work or social life (Taylor et al., CDC MMWR 67(27), 2018 — BRFSS 2015 to 2016).
Men report cognitive complaints at essentially the same rate as women — 11.2% against 10.6% among adults 45 and over.
The category is written almost entirely for women. The data does not support that split (Schliep et al., Biology of Sex Differences, 2022, n=216,838).
There is no routine cognitive screening for adults under 65. Not an oversight — a design decision.
US Preventive Services Task Force guidance covers adults 65 and over, and finds the evidence insufficient even there (USPSTF, 2020). A 45-year-old's annual physical contains no cognitive assessment at all, and none of the drivers behind the change appear on a standard panel.
What This White Paper Will Show You
Written for the high performer between 40 and 65 who has started editing around a brain that used to need no editing.
Why this is common at exactly your age — and why it is neither a women's issue nor a men's issue.
The eight measurable, often-correctable drivers behind it — sleep, apnea, thyroid, B12 and homocysteine, insulin resistance, inflammation, cortisol rhythm, and sex hormones.
What a physician-led approach measures that your annual physical skips — and how it is read against your own history, not a population average.
Where the Evidence Stops
Every claim on this page ships with its source and its limit.
Dementia before 65 is rare.
Dementia before 65 is rare — 293.1 cases per 100,000 globally (Hendriks et al., JAMA Neurology, 2021). Fear framing here is not merely off-tone. It is factually wrong.
A cognitive test is likely to read normal.
Average cognitive performance stays within normal limits for the large majority even where the change is real (Maki and Jaff, Climacteric, 2022). A normal score is the likely result and tells you nothing you did not already know. The useful measurement is the driver panel.
Correction is preventive, not restorative.
Intensive glycemic control did not reverse established cognitive decline (ACCORD-MIND). The defensible claim is preventive and correctable, not restorative — and we will say which one applies to you.
What a randomized trial found for testosterone and cognition.
In a randomized trial of 788 men, testosterone supplementation produced no cognitive difference against placebo (Resnick et al., JAMA, 2017). We measure it and read it in context. We test first. Therapy only when indicated.
You noticed it before any metric did.
The free white paper on why the sharpest people notice the change first, what actually drives it, and why standard medicine almost never measures any of it.
- Why this is common at exactly your age — and not a women's or men's issue
- The eight measurable, often-correctable drivers behind it
- What a physician-led approach measures that your annual physical skips
Where should we send your white paper?
Physician-reviewed · No spam, ever · Unsubscribe anytime · Your information is never shared.